跳至主要内容
临床试验/IRCT201402212954N4
IRCT201402212954N4已完成2 期

The effects of Nicotinic acid on serum phosphorus, PTH and lipid profile in dialysis patients .

Vice chancellor for research, Shahroud University medical and Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 70 years(—)
性别
All

入选标准

  • Age > 15 &<70 years; sign satisfaction; serum phosphorous: 5-7 mg/dl; PTH level > 550 ug/ml; TG >350mg/ml; LDL>150mg/ml and HDL<25 mg/ml; unchanged treatment protocol; (calcium components and Vit D) during last two weeks; unchanged dialysis protocol. Exclusion criteria: pregnancy; known liver disease; active peptic ulcer; carbamazepine use; drug intolerance and not satisfaction of patients.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Shahroud University medical and Sciences

相似试验